Search - tctmd.com

Displaying 101 - 120 of 162

Sort: Relevancy | Date

Presentation TCT 2018

Patient Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall

September 23, 2018

Presentation TCT 2018

FDA Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry

September 23, 2018

Presentation TCT 2018

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari

September 23, 2018

Presentation TCT 2018

ORBITA One Year Later: What Would I Do Differently, If Anything?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee

September 23, 2018

Presentation TCT 2018

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Presenter: Alexander Lauten

September 23, 2018

Presentation TCT 2018

Assessing the Severity of TR: Challenges, Inconsistencies, and Grading Schemes

Presenter: Samir R. Kapadia, Ralph Stephan von Bardeleben, João L Cavalcante

September 23, 2018

Presentation TCT 2018

The Rapid Emergence of Trans-Caval TAVR: Techniques and Clinical Outcomes

Presenter: Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Hiren Mistry

September 22, 2018

Presentation TCT 2018

Japanese Perspective and Experience on RDN Studies

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

Presentation TCT 2018

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Presenter: Rebecca T. Hahn, Jose Luis Navia, Maurizio Taramasso, Henryk Dreger

September 21, 2018

Presentation TCT 2018

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Presenter: Toby Rogers

September 21, 2018

Presentation TCT 2018

Occlusion of the Superior Vena Cava to Reduce Cardiac Filling Pressures is Safe and Feasible in Acutely Decompensated Heart Failure: A First-in-Man Proof of Concept Study

Presenter: Ulrich P. Jorde, John M. Lasala, Navin K. Kapur

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Presenter: Alexander Lauten

June 21, 2018

Presentation ISET 2018

Unique Bioconvertible Inferior Vena Cava Filter: One-year Results from the SENTRY Study

Presenter: Michael Dake

February 04, 2018

Presentation TCT 2017

Transcatheter TR Solution 2: Caval Valve Implantation

Presenter: Francesco Maisano, Jason H. Rogers, Hans R. Figulla

November 01, 2017

Presentation TCT 2017

Technical Opportunities Part 2: Telehealth, Cloud-Based Systems, and Centers of Excellence

Presenter: G. Burkhard Mackensen, Robert J. Siegel, João L Cavalcante

November 01, 2017

Presentation TCT 2017

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Luis F. Angel

November 01, 2017

Presentation TCT 2017

The Emergence of Trans-caval TAVR as a Meaningful Alternative Access Approach

Presenter: Toby Rogers

October 31, 2017

Presentation TCT 2017

TAVR Patient Journey II: Imaging Assessment

Presenter: Martina Kelly Speight, João L Cavalcante

October 30, 2017

Advertisement

Patient Perspectives on Sham-Controlled Trials

FDA Perspectives on Sham-Controlled Trials

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

ORBITA One Year Later: What Would I Do Differently, If Anything?

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Assessing the Severity of TR: Challenges, Inconsistencies, and Grading Schemes

The Rapid Emergence of Trans-Caval TAVR: Techniques and Clinical Outcomes

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Japanese Perspective and Experience on RDN Studies

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Occlusion of the Superior Vena Cava to Reduce Cardiac Filling Pressures is Safe and Feasible in Acutely Decompensated Heart Failure: A First-in-Man Proof of Concept Study

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Unique Bioconvertible Inferior Vena Cava Filter: One-year Results from the SENTRY Study

Transcatheter TR Solution 2: Caval Valve Implantation

Technical Opportunities Part 2: Telehealth, Cloud-Based Systems, and Centers of Excellence

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

The Emergence of Trans-caval TAVR as a Meaningful Alternative Access Approach

TAVR Patient Journey II: Imaging Assessment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content